Метформакс Xr Комби

Metformin Hydrochloride and Sitagliptin combination medication for type 2 diabetes management. Extended-release oral tablets designed to support blood sugar control. Suitable for adults with type 2 diabetes requiring dual therapy. A reliable option for long-term glycemic management.

Metformin Hydrochloride and Sitagliptin is a combination medication used to improve blood sugar control in adults with type 2 diabetes. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity, while Sitagliptin enhances insulin release from the pancreas. This combination helps manage blood sugar levels when diet and exercise alone are insufficient. It is typically prescribed when metformin alone does not achieve target glucose levels.

This medication helps maintain steady blood sugar levels throughout the day, reducing spikes after meals. Users may notice improved energy levels and reduced symptoms of high blood sugar, such as excessive thirst or frequent urination. Some individuals report better overall well-being as glucose control stabilizes. Effects may take several weeks to become fully apparent.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Do not crush or split extended-release tablets unless advised by a healthcare provider. Regular blood sugar monitoring is recommended to track response and adjust therapy as needed. Report any persistent side effects to a medical professional.

Alcohol may increase the risk of lactic acidosis when combined with metformin. Certain medications, such as diuretics or corticosteroids, may affect blood sugar levels. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Avoid combining with other diabetes medications without medical supervision.